Q3 2023 Holdings
Filed 2023-11-14 | 65 holdings | $722.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $35.6M | 540,000 | 4.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $34.4M | 70,000 | 4.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $29.0M | 550,000 | 4.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $28.5M | 500,000 | 3.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $23.6M | 800,000 | 3.3% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $23.5M | 300,000 | 3.3% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $22.9M | 350,000 | 3.2% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $21.7M | 50,000 | 3.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $20.8M | 105,000 | 2.9% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $20.4M | 200,000 | 2.8% |
| Cencora Inc(COR) | COM | 03073E105 | $19.8M | 110,000 | 2.7% |
| Amgen Inc(AMGN) | COM | 031162100 | $17.5M | 65,000 | 2.4% |
| The Cigna Group(CI) | COM | 125523100 | $17.2M | 60,000 | 2.4% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $16.8M | 65,000 | 2.3% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $16.8M | 250,000 | 2.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $16.3M | 175,000 | 2.3% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $14.9M | 430,000 | 2.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $14.5M | 525,000 | 2.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $13.4M | 25,000 | 1.9% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $12.5M | 275,000 | 1.7% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $11.5M | 35,000 | 1.6% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $11.2M | 600,000 | 1.5% |
| Revvity Inc(RVTY) | COM | 714046109 | $11.1M | 100,000 | 1.5% |
| Avantor Inc(AVTR) | COM | 05352A100 | $11.1M | 525,000 | 1.5% |
| Elevance Health Inc(ELV) | COM | 036752103 | $10.9M | 25,000 | 1.5% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $10.3M | 485,000 | 1.4% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $10.2M | 1,000,000 | 1.4% |
| Guardant Health Inc(GH) | COM | 40131M109 | $9.6M | 325,000 | 1.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.6M | 85,000 | 1.3% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $9.0M | 450,000 | 1.2% |
| Lifestance Health Group Inc(LFST) | COM | 53228F101 | $8.9M | 1,300,000 | 1.2% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $8.9M | 800,000 | 1.2% |
| Natera Inc(NTRA) | COM | 632307104 | $8.9M | 200,000 | 1.2% |
| Hologic Inc(HOLX) | COM | 436440101 | $8.7M | 125,000 | 1.2% |
| Moonlake ImmunotherapeuticsPut | PUT | 61559X954 | $8.6M | 150,000 | 1.2% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $8.4M | 748,000 | 1.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $8.1M | 70,000 | 1.1% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $7.9M | 70,000 | 1.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $7.7M | 275,000 | 1.1% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $7.3M | 160,000 | 1.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $7.3M | 275,000 | 1.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $6.9M | 133,000 | 1.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $6.7M | 800,000 | 0.9% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $6.7M | 800,000 | 0.9% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $6.1M | 220,000 | 0.8% |
| Sarepta Therapeutics IncCall | CALL | 803607900 | $6.1M | 50,000 | 0.8% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $5.9M | 200,000 | 0.8% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $5.6M | 250,000 | 0.8% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $5.3M | 450,000 | 0.7% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.1M | 50,000 | 0.7% |